Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -120.24%-20.65M | ---- | -127.30%-9.38M | ---- | 143.77%34.35M | ---- | -44,740.00%-78.47M | ---- | 97.22%-175K | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 141.67%35K | ---- | -25.37%-84K | ---- | -34.00%-67K | ---- | -56.25%-50K | ---- | 13.51%-32K | ---- |
| Attributable subsidiary (profit) loss | -791.67%-1.07M | ---- | -104.23%-120K | ---- | 1,055.22%2.84M | ---- | 10.00%-297K | ---- | 87.41%-330K | ---- |
| Impairment and provisions: | 695.80%19.31M | ---- | 109.64%2.43M | ---- | -179.63%-25.18M | ---- | 6,515.90%31.62M | ---- | -93.44%478K | ---- |
| -Impairment of property, plant and equipment (reversal) | --24.45M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | -346.64%-5.99M | ---- | 109.18%2.43M | ---- | -188.45%-26.45M | ---- | 6,154.81%29.9M | ---- | -93.44%478K | ---- |
| -Other impairments and provisions | --850K | ---- | ---- | ---- | -26.77%1.26M | ---- | --1.73M | ---- | ---- | ---- |
| Revaluation surplus: | -745.25%-8.23M | ---- | --1.28M | ---- | ---- | ---- | 879.25%20.35M | ---- | -3.73%-2.61M | ---- |
| -Other fair value changes | -745.25%-8.23M | ---- | --1.28M | ---- | ---- | ---- | 879.25%20.35M | ---- | -3.73%-2.61M | ---- |
| Asset sale loss (gain): | 49.94%2.56M | ---- | -58.73%1.7M | ---- | -60.88%4.13M | ---- | 408.02%10.56M | ---- | -28,658.33%-3.43M | ---- |
| -Loss (gain) from sale of subsidiary company | 298.04%1.22M | ---- | --306K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | -4.36%1.34M | ---- | -70.24%1.4M | ---- | -52.96%4.7M | ---- | 5,879.64%9.99M | ---- | 1,291.67%167K | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | -199.65%-568K | ---- | 115.86%570K | ---- | ---3.59M | ---- |
| Depreciation and amortization: | -19.80%4.87M | ---- | 43.20%6.08M | ---- | -34.66%4.24M | ---- | -29.99%6.49M | ---- | 11.81%9.28M | ---- |
| Financial expense | -11.80%1.29M | ---- | -7.22%1.47M | ---- | -23.67%1.58M | ---- | 11.35%2.07M | ---- | --1.86M | ---- |
| Special items | -114.27%-984K | ---- | 5,598.35%6.9M | ---- | -95.98%121K | ---- | 1.28%3.01M | ---- | 861.17%2.97M | ---- |
| Operating profit before the change of operating capital | -127.88%-2.86M | ---- | -53.37%10.26M | ---- | 567.16%22.01M | ---- | -158.84%-4.71M | ---- | 15.88%8.01M | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 90.29%7.11M | ---- | 118.47%3.74M | ---- | -76.99%1.71M | ---- | 4,689.51%7.44M | ---- | -117.55%-162K | ---- |
| Accounts receivable (increase)decrease | -219.38%-17.47M | ---- | -82.21%14.63M | ---- | 580.09%82.26M | ---- | 6.11%-17.13M | ---- | -51.42%-18.25M | ---- |
| Accounts payable increase (decrease) | -346.61%-11.75M | ---- | 126.75%4.77M | ---- | -221.37%-17.81M | ---- | -12.16%14.68M | ---- | 257.11%16.71M | ---- |
| prepayments (increase)decrease | 197.63%15.12M | ---- | -177.96%-15.48M | ---- | 280.42%19.86M | ---- | -39.31%-11.01M | ---- | -151.54%-7.9M | ---- |
| Financial assets at fair value (increase)decrease | ---- | ---- | ---- | ---- | -240.63%-585K | ---- | 107.19%416K | ---- | -101.95%-5.79M | ---- |
| Special items for working capital changes | -117.58%-977K | ---- | 113.05%5.56M | ---- | -357.75%-42.61M | ---- | 67.02%16.53M | ---- | 145.95%9.9M | ---- |
| Cash from business operations | -146.14%-10.83M | ---- | -63.79%23.48M | ---- | 944.48%64.83M | ---- | 147.00%6.21M | ---- | 53.79%2.51M | ---- |
| Other taxs | 31.69%-955K | ---- | -323.64%-1.4M | ---- | -522.64%-330K | ---- | 87.98%-53K | ---- | -250.00%-441K | ---- |
| Special items of business | ---- | -731.08%-28.61M | ---- | 63.35%-3.44M | ---- | -134.48%-9.39M | ---- | 9,770.29%27.24M | ---- | 150.92%276K |
| Net cash from operations | -153.38%-11.79M | -731.08%-28.61M | -65.77%22.08M | 63.35%-3.44M | 948.12%64.5M | -134.48%-9.39M | 197.01%6.15M | 9,770.29%27.24M | 7.47%2.07M | 150.92%276K |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -141.67%-35K | ---- | 25.37%84K | ---- | 34.00%67K | ---- | 56.25%50K | ---- | -13.51%32K | ---- |
| Sale of fixed assets | 189.27%8.55M | ---- | 73,775.00%2.96M | ---- | -90.91%4K | ---- | 2,100.00%44K | ---- | --2K | ---- |
| Purchase of fixed assets | -2,057.42%-20.78M | ---- | 98.38%-963K | ---- | -6,487.00%-59.28M | ---- | 71.13%-900K | ---- | -967.47%-3.12M | ---- |
| Sale of subsidiaries | -60.83%358K | ---- | --914K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items in the investment business | ---- | -491.23%-223K | ---- | 105.43%57K | ---61K | -3,520.69%-1.05M | ---- | 98.72%-29K | ---- | -861.70%-2.26M |
| Net cash from investment operations | -498.16%-11.91M | -491.23%-223K | 105.04%2.99M | 105.43%57K | -7,253.97%-59.27M | -3,520.69%-1.05M | 73.86%-806K | 98.72%-29K | -1,109.02%-3.08M | -861.70%-2.26M |
| Net cash before financing | -194.51%-23.69M | -751.65%-28.84M | 379.50%25.07M | 67.58%-3.39M | -2.24%5.23M | -138.38%-10.44M | 628.98%5.35M | 1,471.62%27.21M | -160.43%-1.01M | -155.34%-1.98M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 40.00%35M | ---- | 0.00%25M | ---- | -44.44%25M | ---- | 50.00%45M | ---- | -46.43%30M | ---- |
| Refund | 0.00%-25M | ---- | 0.00%-25M | ---- | 50.00%-25M | ---- | -25.00%-50M | ---- | 28.57%-40M | ---- |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | -84.90%2.84M | ---- | --18.82M | ---- |
| Issuance of bonds | ---- | ---- | --2.86M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | 6.91%-1.29M | ---- | 12.09%-1.39M | ---- | 23.67%-1.58M | ---- | -11.35%-2.07M | ---- | 24.83%-1.86M | ---- |
| Other items of the financing business | --13.31M | 283.24%3.8M | ---- | 25.78%-2.08M | ---- | 87.82%-2.8M | ---- | -416.66%-22.96M | ---- | 929.63%7.25M |
| Net cash from financing operations | 1,298.43%20.61M | 283.24%3.8M | 58.32%-1.72M | 25.78%-2.08M | 39.85%-4.13M | 87.82%-2.8M | -256.47%-6.86M | -416.66%-22.96M | 432.81%4.39M | 929.63%7.25M |
| Effect of rate | -3,264.29%-886K | -98.18%130K | 107.33%28K | 136.66%7.15M | -116.95%-382K | 557.95%3.02M | 140.17%2.25M | -39.53%459K | -215.76%-5.61M | 222.98%759K |
| Net Cash | -113.18%-3.08M | -358.31%-25.03M | 2,020.62%23.35M | 58.75%-5.46M | 172.77%1.1M | -411.38%-13.24M | -144.84%-1.51M | -19.27%4.25M | 35.18%3.37M | 419.02%5.27M |
| Begining period cash | 89.76%49.42M | 89.76%49.42M | 2.84%26.04M | 2.84%26.04M | 3.01%25.32M | 3.01%25.32M | -8.34%24.58M | -8.34%24.58M | 2.75%26.82M | 2.75%26.82M |
| Cash at the end | -8.02%45.46M | -11.58%24.52M | 89.76%49.42M | 83.58%27.73M | 2.84%26.04M | -48.44%15.1M | 3.01%25.32M | -10.81%29.29M | -8.34%24.58M | 33.06%32.85M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | -11.58%24.52M | ---- | 83.58%27.73M | ---- | --15.1M | ---- | ---- | ---- | 33.06%32.85M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | To Baoxin Qin Certified Public Accountants LLP | -- | To Baoxin Qin Certified Public Accountants LLP | -- | To Baoxin Qin Certified Public Accountants LLP | -- | Kaiyuan Xinde Certified Public Accountants Co., Ltd. | -- | Kaiyuan Xinde Certified Public Accountants Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.